Merck develops alternative CRISPR genome editing method
The new method will rapidly deploy newly discovered bacterial CRISPR systems in disease-specific applications
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Govt approves Rs 1500 cr investment to develop bio pharmaceuticals
The primary objective of the programme is to forge an industry-academia collaborative mission for accelerating discovery research…
Indegene and Microsoft in alliance
To deliver new life sciences-focussed business applications
DRL gets US FDA nod for doxorubicin hydrochloride liposome injection
US FDA approval is an outcome of extensive collaboration with the company’s partner, Natco Pharma, on R&D and manufacturing…
Lupin and Lilly expand partnership in India
Exclusive licensing agreement with Eli Lilly will enable Lupin to commercialise and distribute Cialis
Stable economy will drive German pharmaceuticals market to $86.3 billion by 2021
According to GlobalData report, the market will be driven by an increasing elderly population and associated disease burden, while…
Glenmark anti-myeloma drug gets clinical trial nod from US FDA
GBR 1342 is designed to activate the patient's immune system by redirecting immune cells towards tumour tissue, which may lead to…
Mankind Pharma launches anti-hypertensive drug
The drug Azilsartan will offer potent and persistent 24 hours’ blood pressure control
DRL launches Hepatitis C drug in India
DRL's Resof Total tablets are available in bottle count size of 28
CPhI Worldwide to launch global pharma market ranking index
The first-of-a-kind survey will evaluate the relative international reputations of all of the major pharmaceutical economies